# Abacus Global Management, Inc.: financial statements, quarterly

ABX · NYSE · CIK 1814287 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/abx.md) · [Financials](/companies/abx/financials.md) · [Filings](/companies/abx/filings.md) · [Insiders](/companies/abx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/abx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [21.1](/filings/0001814287-24-000054.md) | [23.7 d](/filings/0001814287-25-000006.md) | [21.5](/filings/0001814287-25-000030.md) | [29.1](/filings/0001814287-25-000044.md) | [28.1](/filings/0001628280-25-050614.md) | [33.2 d](/filings/0001628280-26-017775.md) | [44.1](/filings/0001628280-26-033136.md) | [56.2](/filings/0001628280-26-055287.md) | [63.0](/filings/0001628280-25-050614.md) | [71.9 d](/filings/0001628280-26-017775.md) | [59.4](/filings/0001628280-26-033136.md) | [73.0](/filings/0001628280-26-055287.md) |
| Cost of revenue | $m | [3.4](/filings/0001814287-24-000054.md) | [1.7 d](/filings/0001814287-25-000006.md) | [2.7](/filings/0001814287-25-000030.md) | [2.7](/filings/0001814287-25-000044.md) | [2.2](/filings/0001628280-25-050614.md) | [3.7 d](/filings/0001628280-26-017775.md) | [7.1](/filings/0001628280-26-033136.md) | [6.1](/filings/0001628280-26-055287.md) | [7.7](/filings/0001628280-25-050614.md) | [8.0 d](/filings/0001628280-26-017775.md) | [6.3](/filings/0001628280-26-033136.md) | [9.1](/filings/0001628280-26-055287.md) |
| Gross profit | $m | [17.8](/filings/0001814287-24-000054.md) | [22.0 d](/filings/0001814287-25-000006.md) | [18.8](/filings/0001814287-25-000030.md) | [26.3](/filings/0001814287-25-000044.md) | [26.0](/filings/0001628280-25-050614.md) | [29.5 d](/filings/0001628280-26-017775.md) | [37.0](/filings/0001628280-26-033136.md) | [50.2](/filings/0001628280-26-055287.md) | [55.3](/filings/0001628280-25-050614.md) | [63.9 d](/filings/0001628280-26-017775.md) | [53.1](/filings/0001628280-26-033136.md) | [64.0](/filings/0001628280-26-055287.md) |
| Operating income | $m | [6.3](/filings/0001814287-24-000054.md) | [2.0 d](/filings/0001814287-25-000006.md) | [2.3](/filings/0001814287-25-000030.md) | [6.8](/filings/0001814287-25-000044.md) | [6.8](/filings/0001628280-25-050614.md) | [(16.8) d](/filings/0001628280-26-017775.md) | [21.0](/filings/0001628280-26-033136.md) | [22.5](/filings/0001628280-26-055287.md) | [22.4](/filings/0001628280-25-050614.md) | [22.8 d](/filings/0001628280-26-017775.md) | [18.3](/filings/0001628280-26-033136.md) | [21.5](/filings/0001628280-26-055287.md) |
| Interest expense | $m | [2.7](/filings/0001814287-23-000030.md) | [6.2 d](/filings/0001814287-24-000035.md) | [3.7](/filings/0001814287-24-000034.md) | [4.5](/filings/0001814287-25-000044.md) | [4.2](/filings/0001628280-25-050614.md) | [5.9 d](/filings/0001628280-26-017775.md) | [9.6](/filings/0001628280-26-033136.md) | [8.8](/filings/0001628280-26-055287.md) | [9.7](/filings/0001628280-25-050614.md) | [10.7 d](/filings/0001628280-26-017775.md) | [10.5](/filings/0001628280-26-033136.md) | [8.3](/filings/0001628280-26-055287.md) |
| Income tax | $m | [1.7](/filings/0001814287-24-000054.md) | [(0.8) d](/filings/0001814287-25-000006.md) | [1.2](/filings/0001814287-25-000030.md) | [1.8](/filings/0001814287-25-000044.md) | [(0.3)](/filings/0001628280-25-050614.md) | [2.8 d](/filings/0001628280-26-017775.md) | [2.3](/filings/0001628280-26-033136.md) | [4.1](/filings/0001628280-26-055287.md) | [4.7](/filings/0001628280-25-050614.md) | [4.3 d](/filings/0001628280-26-017775.md) | [3.8](/filings/0001628280-26-033136.md) | [4.3](/filings/0001628280-26-055287.md) |
| Net income | $m | [0.9](/filings/0001814287-24-000054.md) | [(6.2) d](/filings/0001814287-25-000006.md) | [(1.3)](/filings/0001814287-25-000030.md) | [0.8](/filings/0001814287-25-000044.md) | [(5.1)](/filings/0001628280-25-050614.md) | [(18.3) d](/filings/0001628280-26-017775.md) | [4.6](/filings/0001628280-26-033136.md) | [17.6](/filings/0001628280-26-055287.md) | [7.1](/filings/0001628280-25-050614.md) | [7.2 d](/filings/0001628280-26-017775.md) | [7.3](/filings/0001628280-26-033136.md) | [6.6](/filings/0001628280-26-055287.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001814287-24-000054.md) | not reported | [(0.02)](/filings/0001814287-25-000030.md) | [0.01](/filings/0001814287-25-000044.md) | [(0.07)](/filings/0001628280-25-050614.md) | not reported | [0.05](/filings/0001628280-26-033136.md) | [0.18](/filings/0001628280-26-055287.md) | [0.07](/filings/0001628280-25-050614.md) | not reported | [0.07](/filings/0001628280-26-033136.md) | [0.07](/filings/0001628280-26-055287.md) |
| Basic EPS | $ per share | [0.01](/filings/0001814287-24-000054.md) | not reported | [(0.02)](/filings/0001814287-25-000030.md) | [0.01](/filings/0001814287-25-000044.md) | [(0.07)](/filings/0001628280-25-050614.md) | not reported | [0.05](/filings/0001628280-26-033136.md) | [0.18](/filings/0001628280-26-055287.md) | [0.07](/filings/0001628280-25-050614.md) | not reported | [0.07](/filings/0001628280-26-033136.md) | [0.07](/filings/0001628280-26-055287.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [36.6](/filings/0001814287-23-000030.md) | [25.6](/filings/0001814287-25-000006.md) | [65.4](/filings/0001814287-24-000034.md) | [91.3](/filings/0001814287-24-000051.md) | [19.4](/filings/0001814287-24-000054.md) | [132](/filings/0001628280-26-017775.md) | [43.8](/filings/0001814287-25-000030.md) | [74.8](/filings/0001814287-25-000044.md) | [86.4](/filings/0001628280-25-050614.md) | [38.1](/filings/0001628280-26-055287.md) | [37.2](/filings/0001628280-26-033136.md) | [23.4](/filings/0001628280-26-055287.md) |
| Current assets | $m | [39.5](/filings/0001814287-23-000030.md) | [31.8](/filings/0001814287-25-000006.md) | [74.3](/filings/0001814287-24-000034.md) | [102](/filings/0001814287-24-000051.md) | [30.8](/filings/0001814287-24-000054.md) | [160](/filings/0001628280-26-017775.md) | [61.5](/filings/0001814287-25-000030.md) | [106](/filings/0001814287-25-000044.md) | [138](/filings/0001628280-25-050614.md) | [69.6](/filings/0001628280-26-055287.md) | [68.3](/filings/0001628280-26-033136.md) | [64.6](/filings/0001628280-26-055287.md) |
| Total assets | $m | [304](/filings/0001814287-23-000030.md) | [332](/filings/0001814287-25-000006.md) | [377](/filings/0001814287-24-000034.md) | [484](/filings/0001814287-24-000051.md) | [477](/filings/0001814287-24-000054.md) | [874](/filings/0001628280-26-017775.md) | [857](/filings/0001814287-25-000030.md) | [848](/filings/0001814287-25-000044.md) | [919](/filings/0001628280-25-050614.md) | [902](/filings/0001628280-26-055287.md) | [830](/filings/0001628280-26-033136.md) | [868](/filings/0001628280-26-055287.md) |
| Current liabilities | $m | [5.5](/filings/0001814287-23-000030.md) | [23.3](/filings/0001814287-25-000006.md) | [23.8](/filings/0001814287-24-000034.md) | [55.4](/filings/0001814287-24-000051.md) | [23.9](/filings/0001814287-24-000054.md) | [62.5](/filings/0001628280-26-017775.md) | [131](/filings/0001814287-25-000030.md) | [140](/filings/0001814287-25-000044.md) | [148](/filings/0001628280-25-050614.md) | [149](/filings/0001628280-26-055287.md) | [35.8](/filings/0001628280-26-033136.md) | [91.7](/filings/0001628280-26-055287.md) |
| Total liabilities | $m | [138](/filings/0001814287-23-000030.md) | [168](/filings/0001814287-25-000006.md) | [211](/filings/0001814287-24-000034.md) | [227](/filings/0001814287-24-000051.md) | [219](/filings/0001814287-24-000054.md) | [451](/filings/0001628280-26-017775.md) | [421](/filings/0001814287-25-000030.md) | [427](/filings/0001814287-25-000044.md) | [479](/filings/0001628280-25-050614.md) | [479](/filings/0001628280-26-055287.md) | [407](/filings/0001628280-26-033136.md) | [428](/filings/0001628280-26-055287.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [342](/filings/0001628280-26-017775.md) | not reported | not reported | [290](/filings/0001628280-25-050614.md) | [290](/filings/0001628280-26-055287.md) | [329](/filings/0001628280-26-033136.md) | [291](/filings/0001628280-26-055287.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0001814287-25-000006.md) | [15.6](/filings/0001814287-24-000034.md) | not reported | [13.7](/filings/0001814287-24-000054.md) | [38.4](/filings/0001628280-26-017775.md) | [1.0](/filings/0001814287-25-000030.md) | [1.0](/filings/0001814287-25-000044.md) | [119](/filings/0001628280-25-050614.md) | [116](/filings/0001628280-26-055287.md) | [1.5](/filings/0001628280-26-033136.md) | [39.8](/filings/0001628280-26-055287.md) |
| Shareholders' equity | $m | [166](/filings/0001814287-24-000054.md) | [164](/filings/0001628280-26-017775.md) | [165](/filings/0001628280-25-050614.md) | [257](/filings/0001628280-25-050614.md) | [258](/filings/0001628280-25-050614.md) | [423](/filings/0001628280-26-055287.md) | [431](/filings/0001628280-26-055287.md) | [417](/filings/0001628280-26-055287.md) | [435](/filings/0001628280-25-050614.md) | [419](/filings/0001628280-26-055287.md) | [418](/filings/0001628280-26-055287.md) | [435](/filings/0001628280-26-055287.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(11.9) d](/filings/0001814287-24-000054.md) | [(13.8) d](/filings/0001814287-25-000006.md) | [2.5](/filings/0001814287-25-000030.md) | [(67.1) d](/filings/0001814287-25-000044.md) | [(52.3) d](/filings/0001628280-25-050614.md) | [(92.0) d](/filings/0001628280-26-017775.md) | [(61.6)](/filings/0001628280-26-033136.md) | [76.1 d](/filings/0001628280-26-055287.md) | [(32.8) d](/filings/0001628280-25-050614.md) | [(7.4) d](/filings/0001628280-26-017775.md) | [91.7](/filings/0001628280-26-033136.md) | [39.3 d](/filings/0001628280-26-055287.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001814287-24-000054.md) | [0.1 d](/filings/0001814287-25-000006.md) | [0.2](/filings/0001814287-25-000030.md) | [0.2 d](/filings/0001814287-25-000044.md) | [0.2 d](/filings/0001628280-25-050614.md) | [0.2 d](/filings/0001628280-26-017775.md) | [0.2](/filings/0001628280-26-033136.md) | [0.4 d](/filings/0001628280-26-055287.md) | [0.2 d](/filings/0001628280-25-050614.md) | [0.1 d](/filings/0001628280-26-017775.md) | [0.1](/filings/0001628280-26-033136.md) | [0.9 d](/filings/0001628280-26-055287.md) |
| Share repurchases | $m | [0.0 d](/filings/0001814287-24-000054.md) | [1.3 d](/filings/0001814287-25-000006.md) | [7.5](/filings/0001814287-25-000030.md) | [3.2 d](/filings/0001814287-25-000044.md) | [0.0 d](/filings/0001628280-25-050614.md) | [0.0 d](/filings/0001628280-26-017775.md) | [0.0](/filings/0001628280-26-033136.md) | [35.1 d](/filings/0001628280-26-055287.md) | [3.2 d](/filings/0001628280-25-050614.md) | [5.5 d](/filings/0001628280-26-017775.md) | [14.5](/filings/0001628280-26-033136.md) | [9.9 d](/filings/0001628280-26-055287.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [50.4](/filings/0001814287-23-000030.md) | [50.4](/filings/0001814287-24-000034.md) | [50.5](/filings/0001814287-24-000051.md) | [63.3](/filings/0001814287-24-000054.md) | [63.0](/filings/0001814287-25-000030.md) | [67.2](/filings/0001814287-25-000044.md) | [74.7](/filings/0001628280-25-050614.md) | [97.5](/filings/0001628280-26-033136.md) | [97.4](/filings/0001628280-26-055287.md) | [96.7](/filings/0001628280-25-050614.md) | [99.5](/filings/0001628280-26-033136.md) | [98.5](/filings/0001628280-26-055287.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 97,792,249 at 2026-07-30, from the cover of the [10-Q filed 2026-08-10](/filings/0001628280-26-055287.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.